Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Purpura, Thrombocytopenic, Idiopathic × eltrombopag × Clear all

Phase

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Classical hematology 1

Conditions

Thrombocytopenia 5 Leukemia, Myeloid, Acute 3 Myelodysplastic Syndromes 2 Sarcoma 1 Purpura, Thrombocytopenic, Idiopathic 1 Myeloproliferative Disorders 1 Leukemia 1 Jacobs syndrome 1 Healthy Adults 1

Interventions

fostamatinib 3 romiplostim 2 eltrombopag 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01957176 2022-12-30

A Rollover Study to Provide Continued Treatment With Eltrombopag

Novartis

Phase 4 Completed

22 enrolled 9 charts

Classical hematologyMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myeloid, Acute, Purpura, Thrombocytopenic, Idiopathic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡